Mayo Clinic and the Translational Genomics Research Institute are launching a national clinical trial using precision medicine to treat advanced melanoma skin cancer.
Mayo Clinic is the only clinical site in
Arizona to offer this new treatment, which is being sponsored by Stand
Up to Cancer and the Melanoma Research Alliance.
The clinical trials are the culmination of
nearly four years of research under an Su2C Melanoma Dream Team grant.
Since then, the TGen dream team has received $6 million under that process and another $4 million from pharmaceutical companies and granting agency partners.
This trial is for patients who have failed conventional therapy.
The study is unique because it will offer
more than 20 different treatment options in a single trial by leveraging
the power of cancer genomics, said Dr. Alan Bryce, Mayo Clinic's lead
clinical investigator on the trial.
No comments:
Post a Comment